Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $507.07 | 23 | 96.6% |
| Education | $17.83 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $327.83 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $107.31 | 5 | $0 (2024) |
| Boston Scientific Corporation | $23.65 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.87 | 1 | $0 (2022) |
| Celltrion USA Inc. | $17.83 | 1 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $17.06 | 1 | $0 (2023) |
| Braintree Laboratories, Inc. | $13.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $348.77 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($243.24) |
| 2023 | $145.15 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($71.48) |
| 2022 | $17.87 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($17.87) |
| 2021 | $13.11 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($13.11) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/21/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: GI COLON PREP | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/27/2023 | Celltrion USA Inc. | YUFLYMA (Biological) | Education | In-kind items and services | $17.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/13/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/30/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 02/28/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Gastroenterology | ||||||
| 08/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 374 | 409 | $741,160 | $38,272 |
| 2022 | 7 | 382 | 420 | $616,090 | $44,152 |
| 2021 | 6 | 373 | 417 | $837,359 | $41,381 |
| 2020 | 5 | 190 | 191 | $260,270 | $13,519 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 218 | 218 | $95,130 | $18,583 | 19.5% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Office | 2023 | 30 | 63 | $235,900 | $5,804 | 2.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 48 | 48 | $26,250 | $5,696 | 21.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 50 | 50 | $22,330 | $4,935 | 22.1% |
| 01942 | Anesthesia for nerve modulation procedure spinal cord or repair of bone of spine of lower back accessed through skin using imaging guidance | Office | 2023 | 14 | 16 | $204,050 | $1,726 | 0.8% |
| 01941 | Anesthesia for nerve modulation procedure spinal cord or repair of bone of spine of neck or upper back accessed through skin using imaging guidance | Office | 2023 | 14 | 14 | $157,500 | $1,529 | 1.0% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 190 | 191 | $84,280 | $20,528 | 24.4% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 50 | 50 | $29,210 | $6,305 | 21.6% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Office | 2022 | 33 | 67 | $232,750 | $6,177 | 2.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 50 | 50 | $24,360 | $5,038 | 20.7% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 34 | 34 | $12,390 | $3,307 | 26.7% |
| 01942 | Anesthesia for nerve modulation procedure spinal cord or repair of bone of spine of lower back accessed through skin using imaging guidance | Office | 2022 | 14 | 15 | $149,450 | $1,659 | 1.1% |
| 01940 | Anesthesia for nerve destruction procedures on spine or spinal cord of lower back accessed through skin using imaging guidance | Office | 2022 | 11 | 13 | $83,650 | $1,139 | 1.4% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 154 | 154 | $91,866 | $15,593 | 17.0% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Office | 2021 | 35 | 56 | $429,100 | $6,047 | 1.4% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 47 | 47 | $46,165 | $5,433 | 11.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 60 | 61 | $47,931 | $5,250 | 11.0% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 54 | 54 | $39,597 | $4,655 | 11.8% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Office | 2021 | 23 | 45 | $182,700 | $4,403 | 2.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 58 | 59 | $74,950 | $3,926 | 5.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 53 | 53 | $64,585 | $2,936 | 4.5% |
| 01922 | Anesthesia for x-ray or radiation therapy | Facility | 2020 | 18 | 18 | $38,220 | $2,615 | 6.8% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 38 | 38 | $45,936 | $2,309 | 5.0% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 23 | 23 | $36,580 | $1,733 | 4.7% |
About Maryann Ophals
Maryann Ophals is a Registered Nurse healthcare provider based in Cave Creek, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609087568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maryann Ophals has received a total of $524.90 in payments from pharmaceutical and medical device companies, with $348.77 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($507.07).
As a Medicare-enrolled provider, Ophals has provided services to 1,319 Medicare beneficiaries, totaling 1,437 services with total Medicare billing of $137,324. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Certified Registered
- Location Cave Creek, AZ
- Active Since 05/24/2007
- Last Updated 04/02/2019
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609087568
Products in Payments
- ENTYVIO (Biological) $327.83
- DUPIXENT (Biological) $107.31
- XIFAXAN (Drug) $17.87
- YUFLYMA (Biological) $17.83
- OCALIVA (Drug) $17.06
- SUTAB (Drug) $13.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Cave Creek
Tara Saenz, Fnp-C, FNP-C
Registered Nurse — Payments: $381.99
Kristen Ash, Rn, RN
Registered Nurse — Payments: $271.84
Nicole Hanna, Np, NP
Registered Nurse
Mrs. Shannon Anaya, Rn, RN
Registered Nurse
Lee Ann Reichow, Rn, RN
Registered Nurse